Asst. Prof. Dr. SÜREYYA YİĞİT KAYA

Hematology

Medipol Mega University Hospital
SÜREYYA YİĞİT KAYA

Birthplace

ELAZIĞ

Languages

ENGLISH

Medical Areas of Interest

  •  Acute and chronic leukemias
  •   Lymphomas
  •   Multiple myeloma
  •   Hematopoietic stem cell transplantation and post-transplant hematological complications
  •   Anemias
  •   Thrombocytopenia and platelet disorders
  •   Coagulation disorders
  •   Hemoglobinopathies
  •   Bone marrow failures
  •   Myeloproliferative diseases
  •   Myelodysplastic syndromes

Highlights

Dr. Süreyya Yiğit Kaya was born in Elazığ in 1984 and is originally from Malatya. She completed her medical education at Istanbul University Cerrahpaşa Faculty of Medicine in 2008.

She completed her residency training in Internal Medicine at Istanbul Medeniyet University Göztepe Training and Research Hospital in 2013, followed by subspecialty training in Hematology at Dokuz Eylül University Faculty of Medicine, which she completed in 2017.

After completing her specialty training, Dr. Süreyya Yiğit Kaya worked as an Internal Medicine Specialist at Sivas Şarkışla State Hospital, followed by positions as a Hematology Specialist at Batman Regional State Hospital and Manisa City Hospital.

Since 2022, she has been working as a physician and lecturer at Medipol Mega University Hospital.

She has numerous articles published in national and international peer-reviewed journals, as well as presentations at scientific meetings, book chapters, and case reports

In March 2026, she was appointed Secretary of the Acute Lymphoblastic Leukemia Scientific Subcommittee (B-ALL Working Group) of the Turkish Hematology Association.

Educations

2017

Dokuz Eylül University Faculty of Medicine, Hematology

2013

Istanbul Medeniyet University Göztepe Training and Research Hospital, Department of Internal Medicine

2008

Istanbul University Cerrahpaşa, Faculty of Medicine

Publications

INTERNATIONAL AND NATIONAL PUBLICATIONS:

Yiğit Kaya S, Mutlu YG, Yücel OK, et al. Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients. Indian J Hematol Blood Transfus. 2025;41(1):38-42. doi:10.1007/s12288-024-01841-8

Kadioglu T, Uzunlulu M, Yigit Kaya S, et al. Urinary kidney injury molecule-1 levels as a marker of early kidney injury in hypertensive patients. Minerva Urol Nefrol. 2016;68(5):456-461.

Kilic Gunes E, Yigit Kaya S, Yaman F, et al. Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience. Leuk Res. 2024;140:107484. doi:10.1016/j.leukres.2024.107484

Yiğit Kaya S, Mutlu YG, Malkan ÜY, et al. Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience. Leuk Res. 2024;140:107495. doi:10.1016/j.leukres.2024.107495

Mutlu YG, Uzunabdullah E, Yahya D, et al. Universal Use of Novel Oral Anticoagulant Prophylaxis in Myeloma Patients Undergoing IMiD-Based Therapy: Real-World Experience. J Clin Med. 2026;15(2):453. Published 2026 Jan 7. doi:10.3390/jcm15020453

Yiğit Kaya S, Kaynar L, Mutlu YG, et al. Myth or reality: Graft versus host disease after autologous hematopoietic cell transplantation, a multicentre experience. Transpl Immunol. 2025;93:102286. doi:10.1016/j.trim.2025.102286

Atas U, Iltar U, Yucel OK, et al. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin. J Clin Med. 2025;14(20):7294. Published 2025 Oct 16. doi:10.3390/jcm14207294

Isleyen E, Alhan N, Terzi Demirsoy E, et al. Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group. J Clin Med. 2025;14(19):6813. Published 2025 Sep 26. doi:10.3390/jcm14196813

Mutlu YG, Emre Ünsal Ş, Güleç B, et al. The Outcomes of Newly Diagnosed Multiple Myeloma Patients With Concurrent or Previous Solid Tumor History. Clin Lymphoma Myeloma Leuk. 2026;26(2):e248-e253. doi:10.1016/j.clml.2025.10.006

Kilic Gunes, E., Yavasoglu, F., Kucukyurt, S. et al. Treatment Outcomes of Elderly Patients with Mantle Cell Lymphoma: A Multi-center Real-World Data. Indian J Hematol Blood Transfus 42, 82–92 (2026). https://doi.org/10.1007/s12288-025-01979-z

Karakus V, Pinar IE, Iltar U, et al. Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry. J Clin Med. 2025;14(20):7367. Published 2025 Oct 18. doi:10.3390/jcm14207367

Kars TU, Göker H, Demiroğlu H, Malkan ÜY, Aladağ Karakulak E, Erdekli FT, Deveci B, Yiğit Kaya S, Kaynar L, Dikyar A, et al. Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World Study. Journal of Clinical Medicine. 2026; 15(13):5045. https://doi.org/10.3390/jcm15135045

Yiğit Kaya S, Vatani M, Maral S, Beköz HS, Abedi AH, Çınar OE, Oluk B, Kaynar L. A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen. Journal of Clinical Medicine. 2026; 15(14):5401. https://doi.org/10.3390/jcm15145401

Yiğit Kaya S, Kadıoğlu T, Uzunlulu M, Oğuz A, İşbilen Başok B. Urinary Neutrophil Gelatinase-Associated Lipocalin Levels as an Indicator of Early Kidney Injury in Patients with Type 2 Diabetes Mellitus. Lokman Hekim Health Sci 2024;4(1):14–19. DOI: 10.14744/lhhs.2023.5001

Ayhan Z, Kaya SY, Ozcan MA, Saatci AO. Brentuximab vedotin related bilateral Purtscher-like retinopathy unresponsive to pulse steroid therapy and intravitreal aflibercept injection. GMS Ophthalmol Cases. 2017;7:Doc29. Published 2017 Dec 15. doi:10.3205/oc000080

Yiğit Kaya S, Askin AE, Bektas S, Çakır A, Gökmen Sevindik Ö. Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder. Leuk Res Rep. 2023;19:100369. Published 2023 May 4. doi:10.1016/j.lrr.2023.100369

Mutlu YG, Yıgıt Kaya S, Maral S, Melek E, Baslar Z, Kaynar L and Sevindik OG (2023) Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case. Front. Immunol. 14:1276295. doi: 10.3389/fimmu.2023.1276295

Özalp, Y.C., Shehabie, H., Tekin, M.G. et al. Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient. BMC Infect Dis 24, 1201 (2024). https://doi.org/10.1186/s12879-024-10074-z

Yiğit Kaya, S., Vatani, M., Akil, R. et al. A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient. Ann Hematol 104, 829–833 (2025). https://doi.org/10.1007/s00277-024-06118-8

Yahya, D., Ayran, M., Özden, F. et al. Successful treatment of steroid-refractory gastrointestinal GVHD with ruxolitinib in a patient after autologous stem cell transplantation: a case report. Int J Hematol 122, 927–931 (2025). https://doi.org/10.1007/s12185-025-04073-2

Yunus Can Ozalp, Senem Maral, Sureyya Yigit Kaya, Huseyin Saffet Bekoz, Leylagul Kaynar, Cutaneous cytomegalovirus infection: a case report, Skin Health and Disease, 2026;, vzaf057, https://doi.org/10.1093/skinhd/vzaf057

Yiğit Kaya, S., Bektas, S., Askin, A.E. et al. Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient. Ann Hematol 102, 1599–1600 (2023). https://doi.org/10.1007/s00277-023-05231-4

Yiğit Kaya S, Akil R, Akyol G, Abedi AH, Çelik S, Kaynar L. Long-Term Response to Single-Agent Lenalidomide in an Elderly Patient with Relapsed Hepatosplenic T-Cell Lymphoma. Turk J Haematol. 2026;43(1):91-92. doi:10.4274/tjh.galenos.2025.2025.0252

Yiğit Kaya, S., Melek, E., Mutlu, Y.G. et al. When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma. Ann Hematol 104, 2079–2080 (2025). https://doi.org/10.1007/s00277-025-06285-2

Akil, R., Yiğit Kaya, S., Beköz, H. S., Çakır, A., & Kaynar, L. (2026). Long-Term Complete Remission Following Lenalidomide-Augmented IVAC/ICE Therapy and Allogeneic Hematopoietic Stem Cell Transplantation in Hepatosplenic T-Cell Lymphoma: A Case Report. Turk J Hematol, 0(0), 0-0. https://doi.org/10.4274/tjh.galenos.2026.13284.

Güven S, Yavuz B, Erdoğan E, Karatas A, Özsan G, Demirkan F, Ündar B, Özcan M, Kiper D, Çetintepe T, Göçer M, Kurtoğlu E, Balık B, Sevindik Ö, Kaya S, Alacacıoğlu İ Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis. Eurasian Journal of Medicine and Oncology. 2023; 7(1): 49 - 56. 10.14744/ejmo.2023.64688

Yiğit Kaya S, Maral S, Abedi AH, Beköz HS, Kaynar L. Venetoclax-based treatment in adult relapsed/refractory acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center real-world experience. J Health Sci Med / JHSM. 2026;9(1):140-146. doi:10.32322/jhsm.1825832

F. Özdemirkıran, Serife Solmaz Medeni, Füsun Özdemirkıran, K. B. Payzın, Kadriye Bahriye Payzın, Ö. G. Sevindik, C. Acar, Ömür Gökmen Sevindik, Celal Acar, D. Türkyılmaz, Doğuş Türkyılmaz, S. Yiğit Kaya, İ. Alacacıoğlu, Süreyya Yiğit Kaya, Ö. Pişkin, İnci Alacacıoğlu, F. Demirkan, Özden Pişkin, H. G. Özsan, Fatih Demirkan, Hayri Güner Özsan, M. A. Özcan, Mehmet Ali Özcan. Evaluation of Patients with Paroxysmal Nocturnal Hemoglobinuria: Experience of Two Centers. DEU Med J. 01 December 2014;28(3):139-43. doi:10.18614/deutfd.40684

Sevindik, Ö. G., Acar, C., Türkyılmaz, D., Kaya, S. Y., Alacacıoğlu, İ., Pişkin, Ö., Özcan, M. A., Demirkan, F., & Özsan, H. G. (2015). Retrospective Evaluation Of Patients Treated With Double Filtration Plasmapheresis. İzmir Training and Research Hospital Medical Journal, 19(4), 181-185. https://izlik.org/JA23BZ27JW

Şerife Solmaz Medeni, Ömür Gökmen Sevindik, Celal Acar, Doğuş Türkyılmaz, Süreyya Yiğit Kaya, Sunay Tunalı, İnci Alacacıoğlu, Özden Pişkin, Fatih Demirkan, Güner Hayri Özsan, Mehmet Ali Özcan, Bülent Ündar. Retrospective Evaluation of Our Patients with Acute Myeloid Leukemia. DEU Med J [Internet]. 01 December 1899;29(2):65-9. Available at: https://izlik.org/JA55JG52NP

Kaya, Sureyya Yigit, et al. "Belinostat in relapsed/refractory peripheral T-cell lymphoma: A real-world multicenter experience." Annals of Medical Research 33.4 (2026): 178-184. https://www.annalsmedres.org/index.php/aomr/article/view/4910

Yiğit Kaya, S. (2023). Recurrent Herpes Infection in Two Cases with Chronic Myeloid Leukemia Using Dasatinib. Muğla Sıtkı Koçman University Medical Journal, 10(1), 65-66. https://doi.org/10.47572/muskutd.1015154

BOOKS AND BOOK TRANSLATIONS:

KAYA, Süreyya YİĞİT, and Güner Hayri ÖZSAN. "AL Amyloidosis." Turkiye Klinikleri Hematology-Special Topics 11.2 (2018): 140-146.

Kaya, S. Y. (2025). Management of acute lymphoblastic leukemia in the elderly patient.

N. A. Soyer, S. Savaş, & F. Şahin (Eds.), Approach to malignant hematologic diseases in the elderly patient (pp.23-29). US Akademi.

Kaya, S. Y. (2023). Vitamin B12 and folic acid deficiency anemia.

D. Çekiç & K. İşsever (Eds.), Current topics in general internal medicine (pp. 15-24). Livre de Lyon.

Kaya SY, Sevindik ÖG. Monoclonal gammopathy of undetermined significance, diagnosis, clinical impact and management.

In: Sevindik ÖG, editor. Multiple myeloma and other plasma cell dyscrasias. Ankara: Türkiye Klinikleri; 2025. p.1-8.

Kaya, S. Y. (2025). Marginal zone lymphoma.

G. Pektaş (Ed.), Pathophysiological foundations of hematologic diseases (Vol. 2, pp. 183-187). Holistence Publications.

Kaya SY. What are the key points to consider in hematology consultation for chronic kidney disease patients developing anemia?

In: Practical consultation approaches in adult hematology. Ankara: Hematology Specialty Association; 2024. p. 70-73.

Lichtman MA, Kaushansky K, Prchal JT, Levi MM, Burns LJ, Linch DC. Williams Manual of Hematology. 10th edition. Tombak A, translation editor. Istanbul: İstanbul Tıp Kitabevi; Year. Chapter 17. Unstable hemoglobins and hemoglobins with altered oxygen affinity.

Memberships

  •  Turkish Hematology Association
  •  Acute Lymphoblastic Leukemia Scientific Subcommittee (B-ALL Working Group) Secretariat, March 2026

Scientific Activities

• Served as an assistant and principal investigator in 30 international, multicenter phase II–III clinical trials.

Certifications

  •  Good Clinical Practice Training
  •  Turkish Hematology Association 7th Hematology Proficiency Exam, November 1, 2018